Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.32
-$0.30 (-1.61%)
At close: Nov 2, 2026, 4:00 PM ET
$18.85
+$0.23 (+1.24%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.97B | 2.18B | 2.2B | 2.41B | 2.48B | 2.23B | 1.9B | 1.64B | 1.5B | 1.4B | 1.24B | 1.1B | 1B | 975.68M | 933.01M | 876.05M | 835.18M | 765.79M | 701.89M | 645.56M | 600.08M | 573.36M |
Cost of Revenue | 818.23M | 821.4M | 839.61M | 573.2M | 514.12M | 406.1M | 319.1M | 230.97M | 176.31M | 165.89M | 150.34M | 136.97M | 139.89M | 143.56M | 139.99M | 140.93M | 124.43M | 106.15M | 97.05M | 87.71M | 79.28M | 73.11M |
Gross Profit | 1.16B | 1.36B | 1.36B | 1.84B | 1.97B | 1.83B | 1.58B | 1.41B | 1.33B | 1.24B | 1.09B | 968.02M | 863.54M | 832.12M | 793.02M | 735.11M | 710.76M | 659.64M | 604.84M | 557.86M | 520.8M | 500.25M |
Operating Income | -143.25M | -40.96M | -699.78M | -126.52M | -932K | -117.21M | 218.08M | 81.03M | 37.99M | -94.83M | -267.82M | -399.28M | -509.8M | -587.41M | -536.2M | -535.18M | -438.28M | -394.73M | -459.71M | -524.61M | -627.22M | -598M |
Interest Income | 29.97M | 30.91M | 36.33M | 42.65M | 52.6M | 64.3M | 71.77M | 79.7M | 84.19M | 86.55M | 85.97M | 72.47M | 57.86M | 39.07M | 19.97M | 10.93M | 2.87M | 510K | 354K | 330K | 304K | 890K |
Pretax Income | -130.92M | 24.47M | -702.23M | -252.19M | -24.13M | -164.19M | 260.77M | 129.4M | 62.22M | 34.06M | -520.1M | -661.78M | -885.02M | -1.1B | -689.96M | -710.55M | -502.04M | -355.7M | -418.95M | -485.54M | -634.04M | -703.08M |
Net Income | -136.73M | 65.06M | -713.41M | -271.51M | -57.96M | -248.39M | 235.24M | 121.85M | 47.3M | 16.9M | -535.98M | -690.88M | -907.68M | -1.12B | -703.49M | -716.23M | -506.63M | -356.56M | -418.78M | -486.12M | -634.47M | -703.89M |
Selling & General & Admin | 436.74M | 467.04M | 491.72M | 527.29M | 563.6M | 564.5M | 557.87M | 525.7M | 518.39M | 498.16M | 481.87M | 470.65M | 454.54M | 490.3M | 451.42M | 409M | 365.34M | 283.37M | 282.66M | 290.65M | 304.9M | 306.24M |
Research & Development | 789.44M | 902.58M | 1.52B | 1.4B | 1.4B | 1.38B | 804.52M | 800.09M | 769.9M | 832.1M | 877.39M | 895.67M | 918.08M | 928.52M | 877.09M | 860.58M | 782.99M | 770.28M | 771.18M | 781.13M | 832.45M | 781.35M |
Other Expenses | 73.18M | 34.13M | 44.63M | 43.06M | 2.47M | 2.41M | 2.41M | 2.57M | 2.4M | 1.98M | 1.56M | 975K | 714K | 714K | 714K | 714K | 714K | 714K | 10.71M | 10.69M | 10.68M | 10.67M |
Operating Expenses | 1.3B | 1.4B | 2.06B | 1.97B | 1.97B | 1.94B | 1.36B | 1.33B | 1.29B | 1.33B | 1.36B | 1.37B | 1.37B | 1.42B | 1.33B | 1.27B | 1.15B | 1.05B | 1.06B | 1.08B | 1.15B | 1.1B |
Interest Expense | 58.35M | 42.07M | 24.86M | 21.77M | 19.12M | 18.73M | 18.39M | 19.15M | 19.46M | 19.85M | 22.01M | 23.46M | 32.97M | 43.78M | 53.25M | 62.61M | 63.87M | 63.67M | 63.53M | 66.21M | 64.1M | 61.98M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.12B | 2.23B | 2.9B | 2.54B | 2.48B | 2.35B | 1.68B | 1.56B | 1.47B | 1.5B | 1.51B | 1.5B | 1.51B | 1.56B | 1.47B | 1.41B | 1.27B | 1.16B | 1.16B | 1.17B | 1.23B | 1.17B |
Income Tax Expense | 5.81M | -40.59M | 11.19M | 19.33M | 33.83M | 84.2M | 25.54M | 7.56M | 14.93M | 17.16M | 15.88M | 29.1M | 22.66M | 16.69M | 13.53M | 5.68M | 4.6M | 854K | -168K | 572K | 431K | 805K |
Shares Outstanding (Basic) | 105.43M | 104.99M | 104.79M | 100.24M | 98.01M | 97.36M | 96.28M | 95.39M | 94.62M | 93.99M | 93.62M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.35M | 87.25M | 84.26M | 79.88M | 79.75M | 79.45M |
Shares Outstanding (Diluted) | 105.43M | 121.92M | 104.79M | 100.24M | 106.62M | 97.36M | 108.47M | 100.45M | 99.14M | 99.11M | 105.59M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.51M | 87.25M | 84.26M | 79.88M | 79.75M | 79.45M |
EPS (Basic) | -1.44 | 0.62 | -7.13 | -2.74 | -0.59 | -2.53 | 2.45 | 1.29 | 0.48 | 0.14 | -6.10 | -7.83 | -10.31 | -12.69 | -8.03 | -8.24 | -5.90 | -4.27 | -5.17 | -6.13 | -8.03 | -8.94 |
EPS (Diluted) | -2.90 | -0.96 | -8.44 | -3.01 | -0.88 | -2.70 | 2.27 | 1.20 | 0.41 | 0.07 | -6.16 | -7.83 | -10.31 | -12.69 | -8.03 | -8.24 | -5.90 | -4.27 | -5.17 | -6.13 | -8.03 | -8.94 |
EBITDA | -14.58M | 124.95M | -619.56M | -180.69M | 36.07M | -106.51M | 316.89M | 187.19M | 121.45M | 95.75M | -453.69M | -594.73M | -808.7M | -1.01B | -594.85M | -606.48M | -396.92M | -252.23M | -317.41M | -384.18M | -538.66M | -611.79M |
EBIT | -59.29M | 79.82M | -664.09M | -230.42M | -5.01M | -145.46M | 279.17M | 148.55M | 81.68M | 53.91M | -498.09M | -638.31M | -852.05M | -1.05B | -636.72M | -647.94M | -438.17M | -292.03M | -355.42M | -419.34M | -569.94M | -641.1M |
Depreciation & Amortization | 44.71M | 45.14M | 44.52M | 49.72M | 41.08M | 38.96M | 37.72M | 38.64M | 39.76M | 41.84M | 44.4M | 43.58M | 43.35M | 42.45M | 41.86M | 41.46M | 41.25M | 39.81M | 38.02M | 35.16M | 31.28M | 29.31M |
Add to Watchlist
Select watchlists to add or remove SRPT